Changing patient characteristics and survival experience in an Alzheimer's center patient cohort

Dementia and Geriatric Cognitive Disorders

Volumn 20, Issue 2-3, 2005, Pages 198-208

  Doody, R ^a   Pavlik, V ^a   Massman, Paul ^a   Kenan, Mary ^a   Yeh, Stephanie ^a   Powell, Suzanne ^a   Cooke, Norma ^a   Dyer, Carmel ^a   Demirovic, Jasenka ^b   Waring, S ^b   Chan, Wenyaw ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Alzheimer's disease; Autopsy; Longitudinal study; Survival

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROPATHOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOMETRY; SURVIVAL RATE; SURVIVAL TIME; TELEPHONE;

AGED; ALZHEIMER DISEASE; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHOMETRICS; SURVIVAL;

EID: 23944435182     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087300     Document Type: Article

References (59)

1. Berg L, Smith DS, Morris JC, et al: Mild senile dementia of the Alzheimer type: 3. Longitudinal and cross-sectional assessment. Ann Neurol 1990;28:648-652.
2. Blessed G, Tomlinson BE, Roth M: The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiat 1968;114:797-811.
3. Oldfield RC: The assessment and analysis of handedness: The Edinburgh inventory. Neuropsychologia 1971;9:97-113.
4. Rosen W, Terry R, Fuld P, Katzman R, Peck A: Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1980;7:486-488.
5. Hughes C, Berg L, Danziger W, Coben L, Martin R: A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-572.
6. Doody R, Dunn JK, Huang E, Azher S, Kataki M: A method for estimating duration of illness in Alzheimer's disease. Dement Geriatr Cogn Disord, 2003;17:1-4.
7. Satz P, Mogel S: An abbreviation of the WAIS for clinical use. J Clin Psychol 1962;18:77-79.
8. Folstein MF, Folstein SE, McHugh PR: 'Mini-Mental State': A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
9. Grober E, Sliwinski M: Development and validation of a model for estimating premorbid verbal intelligence in the elderly. J Clin Exp Neuropsychol 1991;13:933-949.
10. Rosen W, Mohs R, Davis K: A new rating scale for Alzheimer's disease. Am J Psychiatry 1984;141:1356-1364.
11. Wechsler D: Wechsler Memory Scale-Revised. San Antonio, Psychological Corporation. 1987.
12. Warrington EK: Recognition Memory Test. Windsor, PFER-Nelson, 1970.
13. Mahurin R, Cooke N: The Verbal Series Attention Test: Clinical utility in the assessment of dementia. Clin Neuropsychol 1996;1043-1052.
14. Osterrieth P: Le test de copie d'une figure complexe: Contribution a l'étude de la perception et de la memoire. Arch Psychol 1944;30:286-356.
15. Benton AL, Hamsher K: Multilingual Aphasia Examination: Manual of Instructions. Iowa City, AJA Association, 1983.
16. Kaplan E, Goodglass H, Weintraub S: Boston Naming Test. Philadelphia, Lea & Febiger, 1983.
17. Kertesz A: Western Aphasia Battery. New York, Psychological Corporation, 1982.
18. Goodglass H, Kaplan EF: The Assessment of Aphasia and Related Disorders, ed 2. Philadelphia, Lea & Febiger, 1983.
19. Reitan RM, Wolfson D: The Halstead-Reitan neuropsychological test battery: Theory and interpretation. Tucson, Neuropsychology Press, 1985.
20. Luria AR: Higher Cortical Functions in Man. New York, Basic Books, 1966.
21. Lawton MP, Brody EM: Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179-186.
22. Yesavage J, Brink TL, Rose TL: Development and validation of a geriatric depression scale: A preliminary report. J Psychiatr Res 1983;17:37-49.
23. Doody R, Strehlow S, Feher S, Massman P, Roy J, Clark C: The Baylor profound mental status examination: A brief staging measure for profoundly demented Alzheimer's disease patients. Alzheimer Dis Assoc Disord 1999;13:53-59.
24. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease. A report of the NINCDS-ADRDA work group, un der the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
25. Petersen R, Smith G, Waring S, Ivnik R, Tangalos E, Kokmen E: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308.
26. McKeith IG, Galasko D, Kosaka K, et al: Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
27. Roman GC, Tatemichi TK, Erkinjuntt IT, et al: Vascular dementia: Diagnostic criteria for research studies. Neurology 1993;43:250-260.
28. The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994;57:416-418.
29. Neary D, Snowden J, Gustafson L, et al: Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1554.
30. Doody RS, Stevens J, Beck C, et al: Practice Parameter: Management of dementia (an evidence-based review). Neurology 2001;56:1154-1166.
31. Doody R, Massman P, Dunn JK: A method for estimating progression rates in Alzheimer's disease. Arch Neurol 2001;58:449-454.
32. Roccaforte W, Burke W, Bayer B, Wengel S: Validation of a telephone version of the Mini-Mental State Examination. J Am Geriatr Soc 1992;40:697-702.
33. Massman P, Doody R, Davis R: The Baylor assessment of Alzheimer's patients - caregiver questionnaire (BAAP-CQ), submitted.
34. Mirra SS, Heyman A, McKeel D, et al: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
35. Khachaturian ZS: Diagnosis of Alzheimer's Disease. Arch Neurol 1985;42:1097-1105.
36. National Institute on Aging and Reagan Institute Working Group on diagnostic criteria for the neuropathologicsal assessment of Alzheimer's disease: Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 1997;18:S1-S3.
37. Braak H, Braak E: Neuropathologic staging of Alzheimer-related changes. Acta Neuropathol 1991;83:239-259.
38. Thai LT, Grundman M, Klauber MR: Dementia: Characteristics of a referral population and factors associated with progression. Neurology 1988;38:1083-1090.
39. Morris JC, Heyman A, Mohs RC, et al: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-1165.
40. Stern Y, Holstein M, Albert M, et al: Multicenter study of predictors of disease course in Alzheimer disease (the 'predictors study'). I. Study design, cohort description, and intersite comparisons. Alzheimer Dis Assoc Disord 1993;7:3-21.
41. Becker JT, Boller F, Lopez OL, Saxton J, McGonigle KL: Alzheimer's research program. The natural history of Alzheimer's disease. Arch Neurol 1994;51:585-594.
42. Lopez OL, Becker JT, Klunk W, et al: Research evaluation and diagnosis of possible Alzheimer's disease over the last two decades: II. Neurology 2000;55:1863-1869.
43. Flynn JR: The mean IQ of Americans: Massive gains 1932 to 1978. Psychol Bull 1984;95:29-51.
44. Teri L, Hughes JP, Larson EB: Cognitive deterioration in Alzheimer's disease: Behavioral and health factors. J Gerontol 1990;45:58-63.
45. Stern Y, Albert M, Brandt J, et al: Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: Prospective analyses from the Predictors Study. Neurology 1994;44:2300-2307.
46. Botwinick J, Storandt M, Berg L, Boland S: Senile dementia of the Alzheimer type - subject attrition and testability in research. Arch Neurol 1988;45:493-496.
47. Stern Y, Tang M-X, Albert MS, et al: Predicting time to nursing home care and death in individuals with Alzheimer disease. JAMA 1997;277:806-812.
48. Brookmeyer R, Corrada MM, Curriero FC, Kawas C: Survival following a diagnosis of Alzheimer disease. Arch Neurol 2002;59:1764-1767.
49. Waring S, Doody R: Survival in patients with dementia from a large multi-ethnic population (abstract). Neuroepidemiology 2002;21:211.
50. Wolfson C, Wolfson DB, Asgharian M, et al: A reevaluation of the duration of survival after the onset of dementia. N Engl J Med 2001;344:1111-1162.
51. Galasko D, Hansen L, Katzman R, et al: Clinical-neuropathological correlations in Alzheimer's disease and related dementias. Arch Neurol 1994;51:888-895.
52. Villareal D, Grant E, Miller P, Storandt M, McKeel D, Morris J: Clinical outcomes of possible versus probable Alzheimer's disease. Neurology 2003;61:661-667.
53. Doody R, Geldmacher D, Gordon B, Perdomo C, Pratt R: An open-label, multicenter, phase III extension study of the safety and efficacy of donepezil in patients with Alzheimer's disease. Arch Neurol 2001;58:427-433
54. Doody R, Dunn K, Clark C, et al: Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease. Dement Geriatr Cogn Disord 2001;12:295-300.
55. Lopez OL, Becker JT, Wisniewski S, Saxton J, Kaufer DI, DeKosky ST: Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease. J Neurol Neurosurg Psychiatry 2002;72:310-314.
56. Joachim CL, Morris JH, Selkoe DJ: Clinically diagnosed Alzheimer's disease: Autopsy results in 150 cases. Ann Neurol 1988;24:50-56.
57. Mendez MF, Mastri AR, Frey WH: Clinically diagnosed Alzheimer disease: Neuropathologic findings in 650 cases. Alzheimer Dis Assoc Disord 1992;6:35-43.
58. Kazee AM, Eskin TA, Lapham LW, Gabriel KR, McDaniel KD, Hamill RW: Clinicopathologic correlates in Alzheimer disease: Assessment of clinical pathologic diagnostic criteria. Alzheimer Dis Assoc Disord 1993;7:152-164.
59. Gearing M, Mirra AA, Hedreen JC, Sumi SM, Hansen LA, Heyman A: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology 1995;45:461-466.